Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

K-Ras Promotes Angiogenesis Mediated by Immortalized Human Pancreatic Epithelial Cells through Mitogen-Activated Protein Kinase Signaling Pathways
Yoichi Matsuo, Paul M. Campbell, Rolf A. Brekken, et al.
Molecular Cancer Research (2009) Vol. 7, Iss. 6, pp. 799-808
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Helen Ha, Bikash Debnath, Nouri Neamati
Theranostics (2017) Vol. 7, Iss. 6, pp. 1543-1588
Open Access | Times Cited: 633
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Louis Buscail, Barbara Bournet, Pierre Cordelier
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 3, pp. 153-168
Closed Access | Times Cited: 544
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Yuan Cheng, Xuelei Ma, Yuquan Wei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1871, Iss. 2, pp. 289-312
Open Access | Times Cited: 266
Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model
Belinda Gier, Aleksey V. Matveyenko, David Kirakossian, et al.
Diabetes (2012) Vol. 61, Iss. 5, pp. 1250-1262
Open Access | Times Cited: 240
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
Hideaki Ijichi, Anna Chytil, Agnieszka E. Gorska, et al.
Journal of Clinical Investigation (2011) Vol. 121, Iss. 10, pp. 4106-4117
Open Access | Times Cited: 231
KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment
Patrícia Dias Carvalho, Carlos F. Guimarães, Ana Patrícia Cardoso, et al.
Cancer Research (2017) Vol. 78, Iss. 1, pp. 7-14
Open Access | Times Cited: 174
Conformations of KRAS4B Affected by Its Partner Binding and G12C Mutation: Insights from GaMD Trajectory-Image Transformation-Based Deep Learning
Jianzhong Chen, Jian Wang, Wanchun Yang, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 17, pp. 6880-6898
Closed Access | Times Cited: 35
Targeting apoptosis pathways in pancreatic cancer
Alexander Arlt, Susanne Sebens Müerköster, H. Schäfer
Cancer Letters (2010) Vol. 332, Iss. 2, pp. 346-358
Closed Access | Times Cited: 139
Mutant KRAS Conversion of Conventional T Cells into Regulatory T Cells
Stéphanie Zdanov, Magis Mandapathil, Rasha Abu Eid, et al.
Cancer Immunology Research (2016) Vol. 4, Iss. 4, pp. 354-365
Open Access | Times Cited: 134
Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer
Pingping Hou, Avnish Kapoor, Qiang Zhang, et al.
Cancer Discovery (2020) Vol. 10, Iss. 7, pp. 1058-1077
Open Access | Times Cited: 124
Targeting survivin in cancer: the cell-signalling perspective
Jagat R. Kanwar, Sishir K. Kamalapuram, Jagat R. Kanwar
Drug Discovery Today (2011) Vol. 16, Iss. 11-12, pp. 485-494
Closed Access | Times Cited: 117
Hypoxic cancer–associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling
Fernanda G. Kugeratski, Samuel J. Atkinson, Lisa J. Neilson, et al.
Science Signaling (2019) Vol. 12, Iss. 567
Open Access | Times Cited: 103
Iatrogenic endometriosis harbors somatic cancer-driver mutations
Vivian Lac, Lisanne Verhoef, Rosalía Aguirre-Hernández, et al.
Human Reproduction (2018) Vol. 34, Iss. 1, pp. 69-78
Open Access | Times Cited: 90
Blocking CXCLs–CXCR2 axis in tumor–stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment
Makoto Sano, Hideaki Ijichi, Ryota Takahashi, et al.
Oncogenesis (2019) Vol. 8, Iss. 2
Open Access | Times Cited: 83
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review
Rexiati Ruze, Jianlu Song, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non–Small Cell Lung Cancer
Haniel A. Araújo, Ximo Pechuan-Jorge, Teng Zhou, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2183-2208
Closed Access | Times Cited: 12
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Sílvia Casacuberta‐Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Extracellular DNA in Pancreatic Cancer Promotes Cell Invasion and Metastasis
Fushi Wen, Alex Shen, Andrew Choi, et al.
Cancer Research (2013) Vol. 73, Iss. 14, pp. 4256-4266
Open Access | Times Cited: 81
Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
Valentina Comunanza, Federico Bussolino
Frontiers in Cell and Developmental Biology (2017) Vol. 5
Open Access | Times Cited: 79
The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting
Nicolas Jonckheere, Romain Vasseur, Isabelle Van Seuningen
Critical Reviews in Oncology/Hematology (2017) Vol. 111, pp. 7-19
Open Access | Times Cited: 66
CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy–Resistant Glioblastoma
Kartik Angara, Thaiz F. Borin, Mohammad H. Rashid, et al.
Neoplasia (2018) Vol. 20, Iss. 10, pp. 1070-1082
Open Access | Times Cited: 60
Q61 mutant-mediated dynamics changes of the GTP-KRAS complex probed by Gaussian accelerated molecular dynamics and free energy landscapes
Jianzhong Chen, Qingkai Zeng, Wei Wang, et al.
RSC Advances (2022) Vol. 12, Iss. 3, pp. 1742-1757
Open Access | Times Cited: 33
The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers
Jan Korbecki, Mateusz Bosiacki, Katarzyna Barczak, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1406-1406
Open Access | Times Cited: 21
Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer
Dipakkumar R. Prajapati, Caitlin Molczyk, Abhilasha Purohit, et al.
Cancer Letters (2023) Vol. 563, pp. 216185-216185
Closed Access | Times Cited: 18
Zerumbone inhibits tumor angiogenesis via NF-κB in gastric cancer
Ken Tsuboi, Yoichi Matsuo, Tomoya Shamoto, et al.
Oncology Reports (2013) Vol. 31, Iss. 1, pp. 57-64
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top